Fingerprint
Dive into the research topics of 'A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: A study of the mayo phase 2 Consortium (P2C)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 2 study of temsirolimus (CCI-779) in patients with soft tissue sarcomas: A study of the mayo phase 2 Consortium (P2C)
Scott Okuno, Howard Bailey, Michelle R. Mahoney, Douglas Adkins, William Maples, Tom Fitch, David Ettinger, Charles Erlichman, Jann N. Sarkaria
Research output: Contribution to journal › Article › peer-review
70
Scopus
citations